Lenvatinib for large hepatocellular carcinomas with portal trunk invasion: Two case reports

BACKGROUND: In a phase III trial of lenvatinib as first-line treatment for advanced unresectable hepatocellular carcinoma (uHCC), the drug proved non-inferior to sorafenib in terms of the overall survival, but offered better progression-free survival. However, the effects of lenvatinib in uHCC patie...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:World J Clin Cases
Main Authors: Komiyama, Satoshi, Numata, Kazushi, Moriya, Satoshi, Fukuda, Hiroyuki, Chuma, Makoto, Maeda, Shin
Format: Artigo
Sprog:Inglês
Udgivet: Baishideng Publishing Group Inc 2020
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7322437/
https://ncbi.nlm.nih.gov/pubmed/32607334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v8.i12.2574
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker